Apellis Pharmaceuticals
APLS
APLS
48 hedge funds and large institutions have $375M invested in Apellis Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 12 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.54% more ownership
Funds ownership: 31.29% → 33.83% (+2.5%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
48
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$15.3M | |
| 2 | +$8.24M | |
| 3 | +$7.06M | |
| 4 |
BlackRock
New York
|
+$2.98M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.4M |
Top Sellers
| 1 | -$11.1M | |
| 2 | -$6.5M | |
| 3 | -$5.04M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$2.32M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
-$1.95M |